Search results for "HLA Antigen"

showing 10 items of 97 documents

Immunogenetics of longevity. Is major histocompatibility complex polymorphism relevant to the control of human longevity? A review of literature data.

2001

Literature data suggest that human longevity may be directly correlated with optimal functioning of the immune system. Therefore, it is likely that one of the genetic determinants of longevity resides in those polymorphisms for the immune system genes that regulate immune responses. Accordingly, studies performed on mice have suggested that the Major Histocompatibility Complex (MHC), known to control a variety of immune functions, is associated with the life span of the strains. In the last 25 years, a fair number of cross-sectional studies that searched for the role of HLA (the human MHC) genes on human longevity by comparing HLA antigen frequencies between groups of young and elderly pers…

GeneticsAgingPolymorphism Geneticmedia_common.quotation_subjectHaplotypeLongevityLongevityHuman leukocyte antigenImmunogeneticsBiologyMajor histocompatibility complexHistocompatibilityMajor Histocompatibility ComplexMiceImmune systemAntigenHLA AntigensImmunologybiology.proteinImmunogeneticsAnimalsHumansGenetic Predisposition to DiseaseDevelopmental Biologymedia_commonMechanisms of ageing and development
researchProduct

Lack of linkage between gene(s) controlling the synthesis of the seventh component of complement and the HLA region on chromosome No. 6 in man.

1976

The family of an individual was studied who lacks the seventh component of complement in his serum (C7 homozygous deficiency). Both parents are C7 heterozygousdeficient. In this investigation, the following parameters were determined: complement components in functional and immunochemical tests; HLA-A,B antigens, HLA-D (MLC) determinants; the Bf system; glyoxalase I and B cell antigens. No evidence for linkage between the immunogenetic linkage group on chromosome 6 and gene(s) controlling the synthesis of the seventh component of complement was obtained. This is in accordance with the assumption that only genes controlling components of the initiating rather than the membrane attack unit of…

GeneticsChromosomes Human 6-12 and XMaleGenetic LinkageChromosomeHuman leukocyte antigenComplement System ProteinsBiologyComplement factor BHuman geneticsComplement C7Complement (complexity)medicine.anatomical_structureAntigenHLA AntigensHistocompatibility AntigensGeneticsmedicineHumansLymphocyte Culture Test MixedChildGeneGenetics (clinical)B cellHuman genetics
researchProduct

A new polymorphism in the human HFE gene

1999

GeneticsPolymorphism GeneticGenotypeHistocompatibility Antigens Class IHomozygoteMolecular Sequence DataImmunologyHfe geneGenes MHC Class IMembrane ProteinsExonsBiologyHuman geneticsGene FrequencyHaplotypesHLA AntigensGeneticsHumansPoint MutationHemochromatosisHemochromatosis ProteinAllelesImmunogenetics
researchProduct

Anti-HLA immunization of patients qualified for lung transplantation – Single center study

2021

For lung transplantation, the presence of donor-specific anti-HLA antibodies (DSA) is an important factor of antibody-mediated rejection (AMR) in its hyperacute, acute or chronic form during long-term follow up. The aim of the study was to assess the allosensitization of Polish patients qualified for a lung transplantation in our center. A retrospective study of 161 potential lung allograft recipients, also of 31 patients transplanted in the Uni-versity Hospital of Gdansk, between June 2018 and December 2020 were performed. 121 potential recipients were thoroughly tested for immunization status before eventual lung transplantation. SAB-testing, PRA-CDC and vPRA assessment, and HLA typing we…

Graft RejectionAnti-HLA sensitizationTransplantationHistocompatibility TestingImmunologyKidney TransplantationTransplant immunologyHLA AntigensIsoantibodiesHumansImmunology and AllergyImmunizationLung TransplantationRetrospective StudiesTransplant Immunology
researchProduct

14th International HLA and Immunogenetics Workshop: Report on the Prospective Chronic Rejection Project

2007

An international collaborative study of 45 transplant centers was undertaken at the 14th International HLA (human leukocyte antigen) and Immunogenetics Workshop to see if HLA antibodies detected posttransplant are predictive of chronic graft failure. With the newly developed assay, MICA (major histocompatibility complex class I-related chain A) antibodies were also measured and their effect analyzed. Total of 5219 sera from patients who were more than 6 months posttransplant with functioning graft were tested for HLA antibodies by enzyme-linked immunosorbent assay, flow cytometry, or Luminex. HLA antibodies were found in 27.2% of kidney patients, 23.6% in the liver, 52.7% in the heart, and …

Graft RejectionMICA antibodyImmunologyHuman leukocyte antigenHistocompatibility TestingImmunogeneticsMajor histocompatibility complexBiochemistryimmunogenetics workshopchronic rejectionHLA AntigensTransplantation ImmunologyImmunogeneticsGeneticsmedicineHumansImmunology and AllergyHLA antibodyKidneyLungbiologybusiness.industryHistocompatibility TestingGraft SurvivalHistocompatibility Antigens Class IPanel reactive antibodymulti-center studyGeneral MedicineKidney Transplantationmedicine.anatomical_structureChronic DiseaseImmunologybiology.proteinHeart TransplantationAntibodybusinessTissue Antigens
researchProduct

The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapies.

2003

HLA-G as a non-classical MHC class I molecule exhibits a limited tissue distribution and exerts multiple immune regulatory functions including the induction of immune tolerance. In addition, HLA-G has been detected in some tumors of different histology and therefore may represent a novel immune escape mechanism of tumor cells. Despite the immunogenicity of renal cell carcinoma (RCC), outgrowth of tumor cells occurs which might be attributable to abrogation of efficient anti-tumor responses. We here review the potential role of HLA-G in RCC immunology, the HLA-G expression pattern and its functional consequences on immune responses. A heterogenous constitutive and interferon- inducible HLA-G…

HLA-G AntigensCancer ResearchLymphokine-activated killer cellT cellmedicine.medical_treatmentHistocompatibility Antigens Class IHuman leukocyte antigenImmunotherapyBiologyFlow CytometryKidney NeoplasmsImmune toleranceImmunosurveillanceInterferon-gammamedicine.anatomical_structureImmune systemHLA AntigensHLA-GImmunologymedicineCancer researchHumansImmunotherapyRNA MessengerCarcinoma Renal CellSeminars in cancer biology
researchProduct

HLA-G and MIC expression in tumors and their role in anti-tumor immunity.

2003

Non-classical MHC class Ib molecules have attracted growing interest in recent years, especially because they interact with non-T-cell inhibitory or triggering receptors expressed on natural killer (NK) and T cells, suggesting that they have a role in immune recognition. Abnormalities in MHC class Ib expression are frequently found in human tumors of various histologies and might be associated with poor clinical outcome despite the local accumulation of immune competent cells. Available data suggest that the balance between activating and suppressing signals significantly influences the efficacy of the immune response and consequently of tumor progression.

HLA-G AntigensMaleAntitumor immunitybiologyImmunologyHistocompatibility Antigens Class IGene ExpressionGenes MHC Class Ichemical and pharmacologic phenomenaInhibitory postsynaptic potentialAcquired immune systemImmune systemTumor progressionHLA AntigensHLA-GNeoplasmsMHC class IImmunologybiology.proteinImmunology and AllergyHumansFemaleReceptorTrends in immunology
researchProduct

Combined homozygous factor H and heterozygous C2 deficiency in an Italian family

1988

Three of four children in a family have homozygous (less than 1% of normal) deficiency of factor H of the complement system and both parents, who are first cousins, are heterozygous for the same defect. The father and two of the H-deficient siblings also have a partial C2 deficiency. One of the children with combined deficiencies is affected by systemic lupus erythematosus with nephritis. No increased susceptibility to infections has been observed in the family. H deficiency is inherited in an autosomal codominant manner and is independently transmitted from C2 deficiency and HLA haplotypes. In the homozygous state it is associated with very low serum concentrations of B and C3, barely demo…

Heterozygotemedicine.medical_specialtyGenetic LinkageImmunologyHLA AntigensInternal medicineComplement C3b Inactivator ProteinsmedicineHumansLupus Erythematosus SystemicImmunology and AllergyChildImmunoelectrophoresisLupus erythematosusComplement component 2business.industryHomozygoteHeterozygote advantageComplement C2Complement deficiencymedicine.diseasePedigreeComplement systemEndocrinologyComplement Factor HFactor HComplement C3bImmunologyProperdinFemalebusinessNephritisComplement Factor BJournal of Clinical Immunology
researchProduct

Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of n…

2008

The presence of multipotent cells in several adult and embryo-related tissues opened new paths for their use in regenerative medicine. Extraembryonic tissues such as umbilical cord are considered a promising source of stem cells, potentially useful in therapy. The characterization of cells from the umbilical cord matrix (Wharton''s Jelly) and amniotic membrane revealed the presence of a population of mesenchymal-like cells, sharing a set of core-markers expressed by "mesenchymal stem cells". Several reports enlightened the differentiation capabilities of these cells, even if at times the lack of an extensive characterization of surface markers and immune co-stimulators expression revealed h…

HistologyCell Culture TechniquesClinical uses of mesenchymal stem cellsCell SeparationBiologyUmbilical CordHLA AntigensHumansAmnionMolecular BiologyCell ProliferationStem cell transplantation for articular cartilage repairHLA-G AntigensSettore BIO/16 - Anatomia UmanaMultipotent Stem CellsHistocompatibility Antigens Class IMesenchymal stem cellCell DifferentiationMesenchymal Stem CellsAmniotic stem cellsCell BiologyTelomereCord liningCell biologyMedical Laboratory TechnologyMesenchymal stem cells Umbilical cord matrix Differentiation protocols Tolerogenic properties Self-renewal markersAmniotic epithelial cellsImmunologyStem cellOctamer Transcription Factor-3BiomarkersAdult stem cellHistochemistry and Cell Biology
researchProduct

Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.

2003

Abstract Persistent infection with human papillomavirus (HPV), particularly HPV16, represents the prime risk factor in cervical carcinogenesis. HPV variants ( e.g. , within the E6 gene) together with immunogenetic factors of the host may be responsible either for effective viral clearance, or alternatively, for viral persistence. Peripheral blood from 27 HPV16 positive Swedish women with cervical carcinoma, who had previously been tested for HPV16 E6 variants, was used for human leukocyte antigen (HLA) class I typing. Women with HLA-B*44, HLA-B*51, or HLA-B*57 who were infected with the HPV16 E6 variant L83V had an approximately four- to fivefold increased risk for cancer compared with cont…

ImmunologyUterine Cervical NeoplasmsHuman leukocyte antigenBiologyEpitopeHLA AntigensRisk FactorsmedicineImmunology and AllergyHumansGenetic Predisposition to DiseaseTypingAlleleGenePapillomaviridaeCervical cancerSwedenPapillomavirus InfectionsHPV infectionGeneral MedicineOdds ratioOncogene Proteins Viralmedicine.diseaseVirologyRepressor ProteinsTumor Virus InfectionsImmunologyFemaleAlgorithmsHuman immunology
researchProduct